BUT, in 45 days there will be a new variant
Pfizer CEO Albert Bourla on Monday said that his company is aiming to have a vaccine that targets the omicron variant as well as other COVID-19 variants ready in March. “This vaccine will be ready in March,” Bourla said in an appearance on CNBC’s “Squawk Box.” “We [are] already starting manufacturing some of these quantities at risk,” he added.
We are primarily funded by readers. Please subscribe and donate to support us!
See also Vaccine Spike Protein Kills Bifidobacteria in Gut Microbiome, which are extremely important and considered Fountain of Youth
h/t John Dutton